Project Grant R21DE035973
Award Date 8/1/26
Completion Date 7/31/28
Dollars Obligated $432K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Newark, NJ 07107, USA
Similar Awards
- The National Institute of Dental and Craniofacial Research awarded the Regents of the University of Michigan $652,280 on September 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to advance understanding of HPV integration events in oropharyngeal squamous cell carcinoma (OPSCC). The funded research develops novel sequencing and informatics approaches to characterize how human papillomavirus integrates into tumor genomes in HPV-positive OPSCC patients. The work...
- The National Institute of Dental and Craniofacial Research awarded the University of Pittsburgh $1.899 million on September 19, 2025, under the Oral Diseases and Disorders Research program (CFDA 93.121) to analyze high-dimensional genomic datasets of head and neck squamous cell carcinomas and reveal mechanistic insights on divergent clinical outcomes between HPV-positive and HPV-negative tumors using systems biology modeling coupled with experimental validation. The project will employ novel...
- The National Institute of Dental and Craniofacial Research awarded Rutgers The State University of New Jersey $431,750 on September 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to design a novel periodontal vaccine using in silico methodology. The recipient, operating as RBHS-School of Nursing from Newark, New Jersey, will employ subtractive proteomics, structural bioinformatics, reverse vaccinology, and immunoinformatics tools to develop a multivalent,...
- The National Institute of Dental and Craniofacial Research awarded the University of Arizona $284,714 on July 8, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to conduct genomic analysis identifying therapeutic targets for HPV-associated oral cancers, specifically oropharyngeal squamous cell carcinoma driven by HPV16. The research uses gene co-expression network methods to study long non-coding RNAs (lncRNAs) and their regulatory roles across HPV16-driven cervical...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded $433,125 to the University of California, Los Angeles under the Oral Diseases and Disorders Research program (CFDA 93.121) on August 20, 2025, to support a project investigating small molecule inhibitors against human papillomavirus (HPV)-induced oropharyngeal cancers. This R21 pilot project will deliver research services and drug screening capabilities designed to identify therapeutic...
- The National Institute of Dental and Craniofacial Research awarded the University of Pennsylvania $427,839 on August 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop and validate a multimodal imaging platform integrating stimulated Raman scattering (SRS) microscopy with tissue immunofluorescence for spatially resolved metabolic mapping at single-cell resolution in human papillomavirus-positive head and neck squamous cell carcinoma tissue. The research...
- The National Cancer Institute awarded Rutgers The State University of New Jersey $651,548 on July 27, 2026, under the Cancer Treatment Research program (CFDA 93.395) to expand the repertoire of T cell receptor (TCR)-based therapies for human papillomavirus 16 (HPV16)-associated cancers beyond HLA-A*02:01 restriction. The recipient will systematically identify and validate TCRs restricted by prevalent HLA class I alleles including HLA-C07:01, C04:01, C07:02, A01:01, A03:01, and B07:02. Work...
- Federal Grant Award Summary The Ohio State University received a $315,000 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), effective July 15, 2025, through July 14, 2027. This award supports research focused on developing novel antibody therapeutics to target Human Papillomavirus (HPV) oncoproteins E6 and E7 in HPV-positive head and neck cancer (HNC). The research leverages the...
- The National Institute of Allergy and Infectious Diseases awarded Marian University Inc. $208,880 on May 6, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate lysine methylation as a regulatory mechanism of human papillomavirus E2 protein function. The research addresses fundamental HPV biology, specifically how the viral E2 protein—essential for viral genome replication, transcriptional activation, and tethering to host mitotic chromosomes—is regulated...
- Federal Grant Award Summary Baylor College of Medicine received a $320,000 Project Grant from the National Institute of Dental and Craniofacial Research under the Oral Diseases and Disorders Research program (CFDA 93.121) awarded July 15, 2025, with a completion date of July 14, 2027. The research focuses on understanding the mechanisms of radiotherapy resistance in immunologically cold, Human Papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC). The project delivers...